Benjamin A Lerner1, Xavier Llor2. 1. Department of Medicine. Yale University. New Haven, Connecticut. 2. Department of Medicine and Cancer Center. Yale University. New Haven, Connecticut.
Abstract
PURPOSE OF REVIEW: Gastric cancer is a leading cause of cancer death in the world. Between 1% and 3% of cases are associated with specific genetic cancer risk syndromes. The purpose of this article is to review the latest insights, as well as gaps in knowledge, regarding some of the most common hereditary gastric cancer syndromes: hereditary diffuse gastric cancer (HDGC), gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS), Lynch syndrome, the adenomatous polyposis syndromes, and the hamartomatous polyposis syndromes. RECENT FINDINGS: Patients carrying pathogenic variants in CDH1, but not meeting clinical criteria for HDGC, are increasingly being identified thanks to multigene panel testing; their absence from previous analyses overestimated gastric cancer penetrance. GAPPS is a recently described hereditary gastric cancer syndrome associated with specific point mutations in the promoter 1B region of the APC gene. SUMMARY: Risk of gastric cancer is highest among carriers of pathogenic variants in CDH1, with cumulative incidences approximately 40% and 30% for men and women, respectively. Mutations associated with Lynch syndrome and adenomatous polyposis syndromes confer greatest risk for gastric cancer in East Asian populations. Risk of gastric cancer in GAPPS and hamartomatous polyposis syndromes is difficult to estimate due to their rarity, but mutation status likely determines risk. Future research is needed to more precisely define risk of gastric cancer in these syndromes, so strategies for screening and prophylactic gastrectomy can be optimized.
PURPOSE OF REVIEW: Gastric cancer is a leading cause of cancer death in the world. Between 1% and 3% of cases are associated with specific genetic cancer risk syndromes. The purpose of this article is to review the latest insights, as well as gaps in knowledge, regarding some of the most common hereditary gastric cancer syndromes: hereditary diffuse gastric cancer (HDGC), gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS), Lynch syndrome, the adenomatous polyposis syndromes, and the hamartomatous polyposis syndromes. RECENT FINDINGS: Patients carrying pathogenic variants in CDH1, but not meeting clinical criteria for HDGC, are increasingly being identified thanks to multigene panel testing; their absence from previous analyses overestimated gastric cancer penetrance. GAPPS is a recently described hereditary gastric cancer syndrome associated with specific point mutations in the promoter 1B region of the APC gene. SUMMARY: Risk of gastric cancer is highest among carriers of pathogenic variants in CDH1, with cumulative incidences approximately 40% and 30% for men and women, respectively. Mutations associated with Lynch syndrome and adenomatous polyposis syndromes confer greatest risk for gastric cancer in East Asian populations. Risk of gastric cancer in GAPPS and hamartomatous polyposis syndromes is difficult to estimate due to their rarity, but mutation status likely determines risk. Future research is needed to more precisely define risk of gastric cancer in these syndromes, so strategies for screening and prophylactic gastrectomy can be optimized.
Entities:
Keywords:
diffuse gastric cancer; gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS); gastric polyps; hereditary gastric cancer; inherited gastric cancer
Authors: Winifred Lo; Bin Zhu; Arvind Sabesan; Ho-Hsiang Wu; Astin Powers; Rebecca A Sorber; Sarangan Ravichandran; Ina Chen; Lucas A McDuffie; Humair S Quadri; Joal D Beane; Kathleen Calzone; Markku M Miettinen; Stephen M Hewitt; Christopher Koh; Theo Heller; Sholom Wacholder; Udo Rudloff Journal: J Med Genet Date: 2019-02-11 Impact factor: 6.318
Authors: Huiying Ma; Lodewijk A A Brosens; G Johan A Offerhaus; Francis M Giardiello; Wendy W J de Leng; Elizabeth A Montgomery Journal: Pathology Date: 2017-11-21 Impact factor: 5.306
Authors: J Stiekema; A Cats; A Kuijpers; F van Coevorden; H Boot; E P M Jansen; M Verheij; O Balague Ponz; M Hauptmann; J W van Sandick Journal: Eur J Surg Oncol Date: 2013-03-15 Impact factor: 4.424
Authors: Rudolf Repak; Darina Kohoutova; Miroslav Podhola; Stanislav Rejchrt; Marek Minarik; Lucie Benesova; Michal Lesko; Jan Bures Journal: Gastrointest Endosc Date: 2016-06-23 Impact factor: 9.427
Authors: Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas Journal: J Med Genet Date: 2010-07 Impact factor: 6.318